BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 26720744)

  • 1. Long-term Risk of Melanoma-Related Mortality After Uveal Melanoma--Reply.
    Lane AM; Kim IK; Gragoudas ES
    JAMA Ophthalmol; 2016 Feb; 134(2):239-40. PubMed ID: 26720744
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term Risk of Melanoma-Related Mortality After Uveal Melanoma.
    Kivelä T; Kujala E
    JAMA Ophthalmol; 2016 Feb; 134(2):238-9. PubMed ID: 26720623
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term Risk of Melanoma-Related Mortality for Patients With Uveal Melanoma Treated With Proton Beam Therapy.
    Lane AM; Kim IK; Gragoudas ES
    JAMA Ophthalmol; 2015 Jul; 133(7):792-6. PubMed ID: 25905597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive risk factors for radiation retinopathy and optic neuropathy after proton beam therapy for uveal melanoma.
    Seibel I; Cordini D; Hager A; Tillner J; Riechardt AI; Heufelder J; Davids AM; Rehak M; Joussen AM
    Graefes Arch Clin Exp Ophthalmol; 2016 Sep; 254(9):1787-92. PubMed ID: 27376824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cause-specific versus all-cause survival.
    McLean IW; Gamel JW
    Ophthalmology; 1998 Nov; 105(11):1989-90. PubMed ID: 9818594
    [No Abstract]   [Full Text] [Related]  

  • 6. Salvage proton beam therapy in local recurrent uveal melanoma.
    Riechardt AI; Cordini D; Dobner B; Seibel I; Gundlach E; Rehak M; Hager A; Stark R; Moser L; Joussen AM
    Am J Ophthalmol; 2014 Nov; 158(5):948-56. PubMed ID: 25038327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure of preenucleation radiation to decrease uveal melanoma mortality. The Collaborative Ocular melanoma Study Steering Committee.
    Fine SL; Straatsma BR; Earle JD; Hawkins BS; McLaughlin JA
    Am J Ophthalmol; 1989 Apr; 107(4):440-2. PubMed ID: 2929718
    [No Abstract]   [Full Text] [Related]  

  • 8. Preenucleation radiotherapy, uveal melanoma, and competing risks.
    Kivelä T; Kujala E
    Arch Ophthalmol; 2008 Apr; 126(4):580-1; author reply 581-2. PubMed ID: 18413540
    [No Abstract]   [Full Text] [Related]  

  • 9. Local Recurrence After Primary Proton Beam Therapy in Uveal Melanoma: Risk Factors, Retreatment Approaches, and Outcome.
    Seibel I; Cordini D; Rehak M; Hager A; Riechardt AI; Böker A; Heufelder J; Weber A; Gollrad J; Besserer A; Joussen AM
    Am J Ophthalmol; 2015 Oct; 160(4):628-36. PubMed ID: 26133249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival in patients with presymptomatic diagnosis of metastatic uveal melanoma.
    Kim IK; Lane AM; Gragoudas ES
    Arch Ophthalmol; 2010 Jul; 128(7):871-5. PubMed ID: 20625048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controversy regarding pre-enucleation radiation for uveal melanoma.
    Char DH; Phillips TL
    Arch Ophthalmol; 2003 Sep; 121(9):1346. PubMed ID: 12963633
    [No Abstract]   [Full Text] [Related]  

  • 12. [Plaque radiotherapy of uveal malignant melanoma has redeemed its promise].
    Kivelä T
    Duodecim; 1995; 111(16):1521-2. PubMed ID: 9273259
    [No Abstract]   [Full Text] [Related]  

  • 13. 20-year assessment of metastatic latency and subsequent time to death after proton therapy for uveal melanomas.
    Bellocq D; Roy P; Kodjikian L; Mathis T; Nguyen AM; Herault J; Rivoire M; Négrier S; Thariat J; Grange JD
    Melanoma Res; 2020 Jun; 30(3):272-278. PubMed ID: 30320630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Outcomes of Proton Radiotherapy for Uveal Melanoma.
    Verma V; Mehta MP
    Clin Oncol (R Coll Radiol); 2016 Aug; 28(8):e17-27. PubMed ID: 26915706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Posterior uveal melanoma in young patients treated with proton beam therapy.
    Vavvas D; Kim I; Lane AM; Chaglassian A; Mukai S; Gragoudas E
    Retina; 2010 Sep; 30(8):1267-71. PubMed ID: 20224468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of cause-specific melanoma mortality and all-cause mortality in survival analyses after radiation treatment for uveal melanoma.
    Kroll S; Char DH; Quivey J; Castro J
    Ophthalmology; 1998 Nov; 105(11):2035-45. PubMed ID: 9818602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced melanoma-related mortality in uveal melanoma by preenucleation radiotherapy.
    Kilic E; Stijnen T; de Jong PT; Mooy CM; Eijkenboom WM; Ringens PJ; Luyten GP
    Arch Ophthalmol; 2005 Oct; 123(10):1363-7. PubMed ID: 16219727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton teletherapy of uveal melanoma.
    Char DH; Phillips T; Daftari I
    Int Ophthalmol Clin; 2006; 46(1):41-9. PubMed ID: 16365554
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cyclotrons in cancerology: proton therapy used in uveal melanoma. Synthesis of clinical evaluation and guidelines].
    Allouch H
    Presse Med; 2000 Apr 22-29; 29(15):841-4. PubMed ID: 10827791
    [No Abstract]   [Full Text] [Related]  

  • 20. Proton therapy for uveal melanoma in 43 juvenile patients: long-term results.
    Petrovic A; Bergin C; Schalenbourg A; Goitein G; Zografos L
    Ophthalmology; 2014 Apr; 121(4):898-904. PubMed ID: 24405742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.